Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tonix Pharmaceuticals Holding (TNXP) Cash from Financing Activities (2023 - 2025)

Historic Cash from Financing Activities for Tonix Pharmaceuticals Holding (TNXP) over the last 3 years, with Q3 2025 value amounting to $94.9 million.

  • Tonix Pharmaceuticals Holding's Cash from Financing Activities rose 12109.54% to $94.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $240.5 million, marking a year-over-year increase of 16599.1%. This contributed to the annual value of $134.9 million for FY2024, which is 26934.03% up from last year.
  • Latest data reveals that Tonix Pharmaceuticals Holding reported Cash from Financing Activities of $94.9 million as of Q3 2025, which was up 12109.54% from $11.0 million recorded in Q2 2025.
  • In the past 5 years, Tonix Pharmaceuticals Holding's Cash from Financing Activities ranged from a high of $94.9 million in Q3 2025 and a low of -$11.5 million during Q1 2023
  • Moreover, its 3-year median value for Cash from Financing Activities was $11.0 million (2025), whereas its average is $29.7 million.
  • The largest annual percentage gain for Tonix Pharmaceuticals Holding's Cash from Financing Activities in the last 5 years was 2346462.26% (2025), contrasted with its biggest fall of 5648.4% (2025).
  • Over the past 3 years, Tonix Pharmaceuticals Holding's Cash from Financing Activities (Quarter) stood at $40.7 million in 2023, then skyrocketed by 109.15% to $85.2 million in 2024, then grew by 11.4% to $94.9 million in 2025.
  • Its last three reported values are $94.9 million in Q3 2025, $11.0 million for Q2 2025, and $49.5 million during Q1 2025.